The Effect of Sprouting of Wheat on Postprandial Glycemic and Satiety Responses of Wheat Bread Products
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Amanda Wright, Ph.D.
- Phone Number: 54697 519-824-4120
- Email: ajwright@uoguelph.ca
Study Contact Backup
- Name: Iris Joye, Ph.D.
- Phone Number: 52470 519-824-4120
- Email: ijoye@uoguelph.ca
Study Locations
-
-
Ontario
-
Guelph, Ontario, Canada, N1G 2W1
- Human Nutraceutical Research Unit
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy adults
- Age 18-40 years
- Normal non-fasting plasma glucose (<7.9 mmol/L but not below 3.3 mmol/L)
- BMI ranging from 18.5 to 27.9 kg/m2
- Regular consumer of wheat-based bread products (>1x per week).
Exclusion Criteria:
- Smoking or regular use of recreational drugs (marijuana, ecstasy, LSD, magic mushrooms etc.)
- Heavy alcohol use (defined as typically >14 drinks per week or >4 drinks on one occasion)
- Restrained eater (>16) as defined by the questionnaire at screening (Appendix E: Three Factor Eating Questionnaire, Stunkard et al.,1985)
- Unusual sleep patterns (Shift-worker, or sleeps 4 hours or less regularly) or irregular breakfast consumption.
- Recent (i.e. >4 kg in previous 3 months) or intended weight loss or gain
- Food allergies or any life-threatening allergy (food or otherwise)
- Gluten intolerance or sensitivity
- Medications known to affect glucose tolerance (excluding oral contraceptives)
- Presence of disease or drug(s) which influence digestion and absorption of nutrients; including steroids, protease inhibitors or antipsychotics.
- Inability to adhere to Study Protocols
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: White bread
|
Bread portions of 50 gram available carbohydrates.
|
|
Experimental: Sprouted wholemeal bread
|
Bread portions of 50 gram available carbohydrates.
|
|
Active Comparator: Unsprouted wholemeal bread
|
Bread portions of 50 gram available carbohydrates.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postprandial glycemic response
Time Frame: 2 hours
|
Capillary blood glucose
|
2 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postprandial satiety response
Time Frame: 2 hours
|
Hunger, Fullness, Desire to Eat and Prospective Food Consumption questions using Visual Analogue Scales (100 mm lines).
Answers are measured and scored from 0 (not at all) to 100 (extreme).
|
2 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 22-06-26
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.